BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Sun P, Yue Z, Zhang D, You K, Wang J. miR-144-3p Induces Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells by Targeting Proline-Rich Protein 11 Expression via the Mitogen-Activated Protein Kinase Signaling Pathway. DNA and Cell Biology 2017;36:619-26. [DOI: 10.1089/dna.2017.3656] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Ghafouri-Fard S, Shoorei H, Anamag FT, Taheri M. The Role of Non-Coding RNAs in Controlling Cell Cycle Related Proteins in Cancer Cells. Front Oncol 2020;10:608975. [PMID: 33330110 DOI: 10.3389/fonc.2020.608975] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
2 Sun Z, Wu F, Yang Y, Liu F, Mo F, Chen J, Wang G, Zhang B. MiR-144-3p Inhibits BMSC Proliferation and Osteogenic Differentiation Via Targeting FZD4 in Steroid-Associated Osteonecrosis. Curr Pharm Des 2019;25:4806-12. [PMID: 31566128 DOI: 10.2174/1381612825666190930094019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Sun N, Zhang L, Zhang C, Yuan Y. miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/β-catenin signaling. Cell Mol Biol Lett 2020;25:19. [PMID: 32206063 DOI: 10.1186/s11658-020-00210-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
4 Lin C, Xia J, Gu Z, Meng Y, Gao D, Wei S. Downregulation of USP34 Inhibits the Growth and Migration of Pancreatic Cancer Cells via Inhibiting the PRR11. Onco Targets Ther 2020;13:1471-80. [PMID: 32110045 DOI: 10.2147/OTT.S228857] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chen YJ, Guo YN, Shi K, Huang HM, Huang SP, Xu WQ, Li ZY, Wei KL, Gan TQ, Chen G. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data. Respir Res 2019;20:48. [PMID: 30832674 DOI: 10.1186/s12931-019-0994-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
6 Chen C, Zhao C, Gu C, Cui X, Wu J. MiRNA-144-3p inhibits high glucose induced cell proliferation through suppressing FGF16. Biosci Rep 2019;39:BSR20181788. [PMID: 31292167 DOI: 10.1042/BSR20181788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Huang Y, Wang L, Liu D. lncRNA MIR600HG induces the proliferation and invasion of colorectal cancer cells via regulating miR-144-3p/KIF3A. International Immunopharmacology 2022;108:108686. [DOI: 10.1016/j.intimp.2022.108686] [Reference Citation Analysis]
8 Zhou M, Wu Y, Li H, Zha X. MicroRNA-144: A novel biological marker and potential therapeutic target in human solid cancers. J Cancer 2020;11:6716-26. [PMID: 33046994 DOI: 10.7150/jca.46293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Liu P, Yang X, Zhang H, Pu J, Wei K. Analysis of change in microRNA expression profiles of lung cancer A549 cells treated with Radix tetrastigma hemsleyani flavonoids. Onco Targets Ther 2018;11:4283-300. [PMID: 30100735 DOI: 10.2147/OTT.S164276] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Han B, Xu K, Feng D, Bai Y, Liu Y, Zhang Y, Zhou L. miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification. J Cancer Res Clin Oncol 2022. [PMID: 35476233 DOI: 10.1007/s00432-022-03951-0] [Reference Citation Analysis]
11 Huang Y, Ni R, Wang J, Liu Y. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Biomed Pharmacother 2019;109:1851-9. [PMID: 30551440 DOI: 10.1016/j.biopha.2018.09.151] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
12 Yang J, Cong X, Ren M, Sun H, Liu T, Chen G, Wang Q, Li Z, Yu S, Yang Q. Circular RNA hsa_circRNA_0007334 is Predicted to Promote MMP7 and COL1A1 Expression by Functioning as a miRNA Sponge in Pancreatic Ductal Adenocarcinoma. J Oncol 2019;2019:7630894. [PMID: 31428151 DOI: 10.1155/2019/7630894] [Cited by in Crossref: 27] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
13 Song H, Sun H, Pang X, Qian S, Zhang X, Huang Y, Liu X. miR-144-3p Functions as a Tumor Suppressor in Endometrial Cancer by Targeting PRR11. Am J Med Sci 2022:S0002-9629(22)00106-9. [PMID: 35276076 DOI: 10.1016/j.amjms.2022.02.011] [Reference Citation Analysis]
14 Kooshkaki O, Rezaei Z, Rahmati M, Vahedi P, Derakhshani A, Brunetti O, Baghbanzadeh A, Mansoori B, Silvestris N, Baradaran B. MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers. Int J Mol Sci 2020;21:E2578. [PMID: 32276343 DOI: 10.3390/ijms21072578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Bo W, Feng X, Tang X. Overexpression of rhophilin 2 promotes pancreatic ductal adenocarcinoma. Oncol Lett 2021;21:76. [PMID: 33365087 DOI: 10.3892/ol.2020.12337] [Reference Citation Analysis]
16 Ma K, Zhang H, Wang S, Wang H, Wang Y, Liu J, Song X, Dong Z, Han X, Zhang Y, Li H, Rahaman A, Wang S, Baloch Z. The molecular mechanism underlying GABAergic dysfunction in nucleus accumbens of depression-like behaviours in mice. J Cell Mol Med 2019;23:7021-8. [PMID: 31430030 DOI: 10.1111/jcmm.14596] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
17 Sun Y, Liu Z, Huang L, Shang Y. MiR-144-3p inhibits the proliferation, migration and invasion of lung adenocargen cancer cells by targeting COL11A1. J Chemother 2021;:1-11. [PMID: 33845716 DOI: 10.1080/1120009X.2021.1906031] [Reference Citation Analysis]
18 Christou-Kent M, Kherraf ZE, Amiri-Yekta A, Le Blévec E, Karaouzène T, Conne B, Escoffier J, Assou S, Guttin A, Lambert E, Martinez G, Boguenet M, Fourati Ben Mustapha S, Cedrin Durnerin I, Halouani L, Marrakchi O, Makni M, Latrous H, Kharouf M, Coutton C, Thierry-Mieg N, Nef S, Bottari SP, Zouari R, Issartel JP, Ray PF, Arnoult C. PATL2 is a key actor of oocyte maturation whose invalidation causes infertility in women and mice. EMBO Mol Med 2018;10:e8515. [PMID: 29661911 DOI: 10.15252/emmm.201708515] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
19 Li Y, Zhao Y, Cheng M, Qiao Y, Wang Y, Xiong W, Yue W. Suppression of microRNA-144-3p attenuates oxygen-glucose deprivation/reoxygenation-induced neuronal injury by promoting Brg1/Nrf2/ARE signaling. J Biochem Mol Toxicol 2018;32:e22044. [PMID: 29457851 DOI: 10.1002/jbt.22044] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
20 Qian W, Jin F, Zhao Y, Chen Y, Ge L, Liu L, Yang M. Downregulation of microRNA-144 inhibits proliferation and promotes the apoptosis of myelodysplastic syndrome cells through the activation of the AKAP12-dependent ERK1/2 signaling pathway. Cell Signal 2020;68:109493. [PMID: 31809872 DOI: 10.1016/j.cellsig.2019.109493] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Zhou X, Chang Y, Zhu L, Shen C, Qian J, Chang R. LINC00839/miR-144-3p/WTAP (WT1 Associated protein) axis is involved in regulating hepatocellular carcinoma progression. Bioengineered 2021;12:10849-61. [PMID: 34634995 DOI: 10.1080/21655979.2021.1990578] [Reference Citation Analysis]
22 Song L, Chen L, Luan Q, Kong Q. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN. J Cell Physiol 2019;234:17912-24. [PMID: 30834525 DOI: 10.1002/jcp.28424] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
23 Luo J, Xiang Y, Xu X, Fang D, Li D, Ni F, Zhu X, Chen B, Zhou M. High Glucose-Induced ROS Production Stimulates Proliferation of Pancreatic Cancer via Inactivating the JNK Pathway. Oxid Med Cell Longev 2018;2018:6917206. [PMID: 30584464 DOI: 10.1155/2018/6917206] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
24 Yi Q, Liu J, Alexia K, Li J, Luo H, Sun J. [Over-expression of miR-144 inhibits invasion of liver cancer SMMC-7721 cells in vitro by suppressing TLR/MyD88 pathway]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:765-71. [PMID: 32897198 DOI: 10.12122/j.issn.1673-4254.2020.05.25] [Reference Citation Analysis]
25 Pu R, Pu M, Huang H, Cui Y. MicroRNA 144 inhibits cell migration and invasion and regulates inflammatory cytokine secretion through targeting toll like receptor 2 in non-small cell lung cancer. Arch Med Sci 2021;17:1028-37. [PMID: 34336030 DOI: 10.5114/aoms.2020.93084] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Ma K, Zhang H, Wei G, Dong Z, Zhao H, Han X, Song X, Zhang H, Zong X, Baloch Z, Wang S. Identification of key genes, pathways, and miRNA/mRNA regulatory networks of CUMS-induced depression in nucleus accumbens by integrated bioinformatics analysis. Neuropsychiatr Dis Treat 2019;15:685-700. [PMID: 30936699 DOI: 10.2147/NDT.S200264] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
27 Ye MH, Zhao ZS, Ru GQ, He XL. Expression of PRR11 protein in gastric cancer: Correlation with disease progression and prognosis. Shijie Huaren Xiaohua Zazhi 2018; 26(2): 80-86 [DOI: 10.11569/wcjd.v26.i2.80] [Reference Citation Analysis]
28 Liu C, Yang Z, Deng Z, Zhou Y, Gong Q, Zhao R, Chen T. Downregulated miR-144-3p contributes to progression of lung adenocarcinoma through elevating the expression of EZH2. Cancer Med 2018;7:5554-66. [PMID: 30280514 DOI: 10.1002/cam4.1714] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
29 Deng B, Wang M, Liu Z. A panel of 8 miRNAs as a novel diagnostic biomarker in pancreatic cancer. Medicine (Baltimore) 2020;99:e22261. [PMID: 32957376 DOI: 10.1097/MD.0000000000022261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Wang J, Liu S, Shi J, Li J, Wang S, Liu H, Zhao S, Duan K, Pan X, Yi Z. The Role of miRNA in the Diagnosis, Prognosis, and Treatment of Osteosarcoma. Cancer Biother Radiopharm 2019;34:605-13. [PMID: 31674804 DOI: 10.1089/cbr.2019.2939] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 5.7] [Reference Citation Analysis]
31 Tokar T, Pastrello C, Ramnarine VR, Zhu CQ, Craddock KJ, Pikor LA, Vucic EA, Vary S, Shepherd FA, Tsao MS, Lam WL, Jurisica I. Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes. Oncotarget 2018;9:9137-55. [PMID: 29507679 DOI: 10.18632/oncotarget.24070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]